New Zealand markets closed

Checkpoint Therapeutics Inc (CZTA.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.7420+0.0220 (+1.28%)
At close: 09:53PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
134
103
192
268
1,069
-
Operating expenses
Research development
63,247
43,566
49,825
48,453
16,352
-
Selling general and administrative
8,346
8,685
8,700
8,538
7,918
-
Total operating expenses
71,593
52,251
58,525
56,991
24,270
-
Operating income or loss
-71,459
-52,148
-58,333
-56,723
-23,201
-
Total other income/expenses net
-7,350
217
-4,451
-
-
-
Income before tax
-71,358
-51,847
-62,624
-56,670
-23,081
-
Income from continuing operations
-71,358
-51,847
-62,624
-56,670
-23,081
-
Net income
-71,358
-51,847
-62,624
-56,670
-23,081
-
Net income available to common shareholders
-71,358
-51,847
-62,624
-56,670
-23,081
-
Basic EPS
-4.38
-
-7.09
-7.45
-4.10
-7.00
Diluted EPS
-4.38
-
-7.09
-7.45
-4.10
-7.00
Basic average shares
14,188
-
8,836
7,603
5,583
3,530
Diluted average shares
14,188
-
8,836
7,603
5,583
3,530